| Janice M Douglas, AA | |
|
3714 Guardian Ave Ste W, Morehead City, NC 28557-2975 | |
| (252) 648-0409 | |
| Not Available |
| Full Name | Janice M Douglas |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 36 Years |
| Location | 3714 Guardian Ave Ste W, Morehead City, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629090998 | NPI | - | NPPES |
| 000000232159 | Other | OH | UNISON |
| 430027428 | Other | OH | RAILROAD MEDICARE |
| 414964 | Other | OH | WELLCARE MEDICAID |
| 7758969 | Other | OH | AETNA |
| 0583328 | Other | OH | BCMH |
| 000000515963 | Other | OH | ANTHEM |
| 2268264 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 1000-00835 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Anesthesiology Of North Carolina Pllc | 2961316450 | 383 |
News Archive
Apparently not very much, according to a study by Dutch investigators published in the Jan 2008 issue of Psychotherapy and Psychosomatics.
Combining partially differentiated stem cells with gene therapy can promote the growth of new "insulation" around nerve fibers in the damaged spinal cords of rats, a new study shows.
Research presented at the American Diabetes Association's 71st Scientific Sessions (ADA) this week adds to the clinical evidence for Medtronic's sensor-augmented insulin pump therapy for improved glucose control for people with type 1 diabetes.
Geron Corporation today announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1. The primary objective of this Phase I study is to assess the safety and tolerability of GRNOPC1 in patients with "complete" American Spinal Injury Association (ASIA) Impairment Scale grade A thoracic spinal cord injuries. Participants in the study must be newly injured and receive GRNOPC1 within 14 days of the injury.
Use of selective serotonin reuptake inhibitors is associated with an increased risk for brain hemorrhage, particularly intracerebral bleeding, suggest meta-analysis findings.
› Verified 6 days ago
| Entity Name | American Anesthesiology Of North Carolina Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053677195 PECOS PAC ID: 2961316450 Enrollment ID: O20031229000004 |
News Archive
Apparently not very much, according to a study by Dutch investigators published in the Jan 2008 issue of Psychotherapy and Psychosomatics.
Combining partially differentiated stem cells with gene therapy can promote the growth of new "insulation" around nerve fibers in the damaged spinal cords of rats, a new study shows.
Research presented at the American Diabetes Association's 71st Scientific Sessions (ADA) this week adds to the clinical evidence for Medtronic's sensor-augmented insulin pump therapy for improved glucose control for people with type 1 diabetes.
Geron Corporation today announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1. The primary objective of this Phase I study is to assess the safety and tolerability of GRNOPC1 in patients with "complete" American Spinal Injury Association (ASIA) Impairment Scale grade A thoracic spinal cord injuries. Participants in the study must be newly injured and receive GRNOPC1 within 14 days of the injury.
Use of selective serotonin reuptake inhibitors is associated with an increased risk for brain hemorrhage, particularly intracerebral bleeding, suggest meta-analysis findings.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Janice M Douglas, AA 411 Emerald Landing Dr, Emerald Isle, NC 28594-2407 Ph: (440) 289-5253 | Janice M Douglas, AA 3714 Guardian Ave Ste W, Morehead City, NC 28557-2975 Ph: (252) 648-0409 |
News Archive
Apparently not very much, according to a study by Dutch investigators published in the Jan 2008 issue of Psychotherapy and Psychosomatics.
Combining partially differentiated stem cells with gene therapy can promote the growth of new "insulation" around nerve fibers in the damaged spinal cords of rats, a new study shows.
Research presented at the American Diabetes Association's 71st Scientific Sessions (ADA) this week adds to the clinical evidence for Medtronic's sensor-augmented insulin pump therapy for improved glucose control for people with type 1 diabetes.
Geron Corporation today announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1. The primary objective of this Phase I study is to assess the safety and tolerability of GRNOPC1 in patients with "complete" American Spinal Injury Association (ASIA) Impairment Scale grade A thoracic spinal cord injuries. Participants in the study must be newly injured and receive GRNOPC1 within 14 days of the injury.
Use of selective serotonin reuptake inhibitors is associated with an increased risk for brain hemorrhage, particularly intracerebral bleeding, suggest meta-analysis findings.
› Verified 6 days ago
Amy N Armstrong, AA-C Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 3714 Guardian Ave, Suite E, Morehead City, NC 28557 Phone: 252-222-5862 Fax: 252-247-4675 | |
Kristin C Gray, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3714 Guardian Ave, Suite W, Morehead City, NC 28557 Phone: 252-247-0314 |